Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...

Suboxone (buprenorphine/naloxone) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat opioid dependence. This condition is now called opioid use ...

SAN DIEGO--(BUSINESS WIRE)--Millennium Health, an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of ...

Please provide your email address to receive an email when new articles are posted on . Patients with untreated opioid use disorder responded well to a high-dose induction of buprenorphine in the ED, ...

The myth that Suboxone “swaps one addiction for another” is false. But that doesn’t mean there aren’t any risks with taking it. Medication assisted treatment (MAT) is considered the gold standard for ...

Heavy fentanyl users may derive greater benefit from a higher dose of extended-release buprenorphine maintenance therapy, a randomized controlled trial suggests.

Suboxone can cause mild side effects such as headache, nausea, and constipation. Serious side effects can also occur from receiving Suboxone, though these are rare. Examples include respiratory ...